Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boni Elewski

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Mycoses|January 12, 2024
Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agentsAditya K Gupta, Boni Elewski, Warren S Joseph, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the USShari R Lipner, Warren S Joseph, Tracey C Vlahovic, et al.
American Journal of Clinical Dermatology|March 18, 2024
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal ResistanceRachel C Hill, Avrom S Caplan, Boni Elewski, et al.
The Journal of Dermatological Treatment|July 4, 2019
Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasisBoni Elewski, Alan Menter, Jeffrey Crowley, et al.
Journal of Drugs in Dermatology : JDD|January 6, 2026
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian ParticipantsShari R Lipner, Aditya K Gupta, Tracey C Vlahovic, et al.
The Journal of Dermatological Treatment|March 9, 2026
Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 yearsPaolo Gisondi, Boni Elewski, Andreas Pinter, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric PatientsLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.
The British Journal of Dermatology|March 8, 2022
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritisKristian Reich, Xenophon Baraliakos, Laura C Coates, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 StudiesMelinda J Gooderham, Boni Elewski, Matthias Augustin, et al.
Dermatology and Therapy|November 22, 2024
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled TrialsJoseph F Merola, Alice B Gottlieb, Andreas Pinter, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Mycoses|January 12, 2024
Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agentsAditya K Gupta, Boni Elewski, Warren S Joseph, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
Therapeutic Recommendations for the Treatment of Toenail Onychomycosis in the USShari R Lipner, Warren S Joseph, Tracey C Vlahovic, et al.
American Journal of Clinical Dermatology|March 18, 2024
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal ResistanceRachel C Hill, Avrom S Caplan, Boni Elewski, et al.
The Journal of Dermatological Treatment|July 4, 2019
Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasisBoni Elewski, Alan Menter, Jeffrey Crowley, et al.
Journal of Drugs in Dermatology : JDD|January 6, 2026
Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian ParticipantsShari R Lipner, Aditya K Gupta, Tracey C Vlahovic, et al.
The Journal of Dermatological Treatment|March 9, 2026
Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 yearsPaolo Gisondi, Boni Elewski, Andreas Pinter, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric PatientsLawrence F Eichenfield, Boni Elewski, Jeffrey L Sugarman, et al.
The British Journal of Dermatology|March 8, 2022
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritisKristian Reich, Xenophon Baraliakos, Laura C Coates, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 StudiesMelinda J Gooderham, Boni Elewski, Matthias Augustin, et al.
Dermatology and Therapy|November 22, 2024
Bimekizumab Efficacy in High-Impact Areas: Pooled 2-Year Analysis in Scalp, Nail, and Palmoplantar Psoriasis from Phase 3/3b Randomized Controlled TrialsJoseph F Merola, Alice B Gottlieb, Andreas Pinter, et al.
Pageof 6